期刊文献+

卡维地洛治疗充血性心力衰竭的临床疗效

Observation of the clinical effect of Carvedilol in the treatment of congestive heart failure
下载PDF
导出
摘要 目的观察卡维地洛治疗充血性心力衰竭的疗效。方法将124例充血性心力衰竭患者随机分为治疗组和对照组,在常规强心、利尿、扩血管药物治疗基础上,治疗组加用卡维地洛治疗24周,观察两组治疗效果。结果卡维地洛对改善充血性心力衰竭患者临床症状、体征及心脏收缩功能、舒张功能均有显著效果。结论在常规抗心力衰竭治疗的基础上加用卡维地洛能明显改善患者的心功能,提高患者的生存率。 Objective To observe the curative effect of carvedilol in the treatment of congestive heart failure. Meth- ods 124 patients with congestive heart failure were randomly divided into the treatment group and control group, carvedilo] was used in the treatment group on the base of routine therapy including digitalis,diuretics and vasodilators. Results Carve- dilol has a significant effect to improve in patients with congestive heart failure clinical symptoms, signs and systolic function, diastolic function. Conclusion On the base of routine anti heart failure drug therapy, earvedilol could significantly improve cardiac function in patients with congestive heart failure, and improve survival rate.
作者 吴霰
出处 《中国医学创新》 CAS 2011年第6期35-36,共2页 Medical Innovation of China
关键词 充血性心力衰竭 卡维地洛 Congestive heart failure Carvedilol
  • 相关文献

参考文献6

  • 1郑晔,李永星,刘刚,刘超,韩立宪,刘坤申.卡维地洛治疗舒张性心力衰竭研究进展[J].中国心血管杂志,2008,13(5):377-379. 被引量:11
  • 2Ruffolo RR, Gallai M, Hieble JP, et al. The pharmacology of carve- dilol. Eur J Clin Pharmacol, 1990,38 : $82 - $88.
  • 3Australiz/New Zealand Heart Failure Research Collaborative Group. Randomised, Placebo - controlled trim of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet, t997, 349:373 - 380.
  • 4王夜明,赵莹,庞靓,熊智敏.卡维地洛治疗慢性充血性心力衰竭24例临床分析[J].中国医师杂志,2003,5(9):1282-1283. 被引量:2
  • 5肖琼林,薛伟.β-受体阻滞剂在心力衰竭的应用现状.第二十一届航天医学年会暨第四届航天护理年会论文汇编(下册),2005.
  • 6赵晓辉,李隆贵,于金秋,等.卡维地洛治疗慢性心力衰竭疗效及安全性分析.中华医学会心血管病分会第八次全国心血管病学术会议汇编,2004.

二级参考文献25

  • 1Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces doserelated improvements in left venticular function and survival in subjevts with chronic heart failure. MOCHA investigators[J]. Circulation, 1996,94:2807~ 2816.
  • 2Packer M. Beta - adrenergic blockade in chronic heart failure: principles,progress, and practice[J]. Prog Cardiovase Dis,1996,48:39-52.
  • 3Packer M, Cohn JN. Consensus recommendations for the management of chronic heart failure[J]. Am J Cardiol, 1999, 83(suppl 2A): 1A -38A.
  • 4Metra M, Modena M, Giubbini R, et al. Differential effects of beta- blockers in patients with heart fauilure .A prospective, randomized, double- blind comparison of the long- term effects of metoptolol versus carvedilol[ J]. Circulation,2000,102:546 - 551.
  • 5Doughty RN, Rodger A, Sharpe N, et al. Effects of beta - blocker therapy on mortality in patiets with heart failure: a systematic overview of randomized controlled trials[J]. Eur Heart J,1997,18:560.
  • 6Feuerstein GZ, Bril A, Ruffolo-JrRR. Protective efects of carvedilol in the myocardium[J]. Am J Cardiol, 1997,80(11A) : 41L - 42L.
  • 7Billman GE, Castillo LC, Henaley J, et al.B2- adrenergic receptor antagonists protect against ventrcular fibrillation. In vivi and vitro evidence for enhanced sensitivity toB2 - adrenergc stimulation in animals susceptible for sudden death[J]. Circulation, 1997,96:1914.
  • 8Bristow MR. Mechanism of action of beta - blocking agent in heart failure[J].Am J Cardiol, 1997,80( 11 A) : 26L.
  • 9Zhang Y,Zhong M, Zhang W, et al. Difference sinsar coplas micreticulum geneexpression in diastolic heart failure in rabbit. J Heart Failure ,2000,6:69.
  • 10Kostin S, Hein S, Arnon E, et al. The cytoskeleton and related proteins in the human failing heart, lleart Fail Rev ,2000,5:271 - 280.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部